The Life Sciences team advised on the launch of Nested Therapeutics and its $125 million in financing, including its initial financing by Versant Ventures and its $90 million Series A financing led by Goldman Sachs Asset Management, along with additional investors Versant Ventures, Foresite Capital, Cowen Healthcare Investments, Avidity Partners and Section 32.
Nested Therapeutics is a biotechnology company focused on discovering and developing novel, targeted, small molecule precision medicine therapies for patients with cancer by using mutation clusters to identify druggable pockets. With a platform that utilizes insights from genomics, computational chemistry, proteomics, and AI, Nested is working to reach untapped mutations with the potential to improve outcomes for millions of patients.
The Goodwin team was led by Mayan Katz and Robert Puopolo, and included Noga Benmor-Piltch, Amarilice Young, Sara Lepis, Ana Carolina Zattar, Alex Denniston and Christina Lewis.
For more details, please read the press release.